___

• 1. Kumar Y, Bhatia A, Minz RW. Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited. Diagn Pathol 2009;4:1. [CrossRef]
• 2. Pisetsky DS. Antinuclear antibodies in healthy people: the tip of autoimmunity’s iceberg? Arthritis Res Ther 2011;13:109-10. [CrossRef]
• 3. Marin GG, Cardiel MH, Cornejo H, Viveros ME. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases. J Clin Rheumatol 2009;15:325-9. [CrossRef]
• 4. de Vlam K, De Keyser F, Verbruggen G, Vandenbossche M, Vanneuville B, D’Haese D, et al. Detection and identification of antinuclear autoantibodies in the serum of normal blood donors. Clin Exp Rheumatol 1993;11:393-7.
• 5. Vazquez-Del Mercado M, Gonzalez-Bernaldez M, Garcia-De La Torre I. Prevalence of antinuclear antibodies in a Huichol population of Mexico. Lupus 1995;4:164-5. [CrossRef]
• 6. Fernandez SA, Lobo AZ, Oliveira ZN, Fukumori LM, P rigo AM, Rivitti EA. Prevalence of antinuclear autoantibodies in the serum of normal blood donors. Rev Hosp Clín Fac Med S Paulo 2003;58:315-9. [CrossRef]
• 7. Al Jabri AA, Al Belushi MS, Nsanze H. Frequency and levels of otoantibodies in healthy adult Omanis. Ann Saudi Med 2003;23:372-5.
• 8. Satoh M, Chan EK, Ho LA, Rose KM, Parks CG, Cohn RD, et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum 2012;64:2319-27. [CrossRef]
• 9. Hayashi N, Koshiba M, Nishimura K, Sugiyama D, Nakamura T, Morinobu S, et al. Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol 2008;18:153-60. [CrossRef]
• 10. Topbas M, Can E, Kaklikkaya N, et al. Herpes Simplex-2 seroprevalence among adults aged 20-49 in Trabzon. Nobel Med 2012;8:85-90.